Skip to main content
. 2019 Dec 2;10:5492. doi: 10.1038/s41467-019-13420-x

Fig. 4.

Fig. 4

Lower ELP5 expression is correlated with drug resistance and downregulated P53 function in GBC patients. a Drug resistance-related biological signatures were enriched GBC specimens with low ELP5 expression. b Cell cycle, DNA damage, senescence, and P53-related biological signatures were dysregulated in GBC specimens with low ELP5 expression. c Heat map of P53 target genes that were downregulated in GBC specimens with low ELP5 expression (n = 6) compared to those with high ELP5 expression (n = 4).